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PATIENTS with malignant disease may be submitted to treatment with cyto-
toxic drugs before, during, or soon after surgery. It is known, however, that these
agents have a destructive action on all actively dividing cells, both normal and
neoplastic. Therefore, it is possible that if they are administered in combination
with a surgical procedure they may have an inhibitory effect on wound healing as
well as on the growth of tumour cells. The surgeon must be constantly aware of
this. He should know which drugs are likely to influence the healing of his
wounds, and at what stage their administration will have the greatest adverse
effect.
The present series ofexperiments was designed to test the influence ofnitrogen
mustard, streptonigrin and A.G.N. 1414 on the healing of peritoneal wounds.
The latter two drugs have recently been undergoing clinical trials in the Prof-
essorial Surgical Unit at the Westminster Hospital.
MATERIALS AND METHODS
The animals.-Adult male Wistar rats weighing 250-350 g. were used. The
animals were fed with Dixon's 41B diet, and were allowed water ad libitum.
The operative procedure.-This was identical in all the rats. Anaesthesia was
induced by intraperitoneal injection of 6 % pentobarbitone. The skin of the
anterior abdominal wall was then shaved and sprayed with 70% spirit.
A midline incision was used to open the abdominal cavity. Bilateral peritoneal
defects were made in the anterior abdominal wallby excising an area ofperitoneum
approximately 1 sq cm. in size, together with some underlying muscle, on each
side. The incision was closed with a single continuous suture of 'o' silk.
Cytotoxic therapy.-Nitrogen mustard, streptonigrin and A.G.N. 1414
(N-ethyl-N-,8-chloroethyl-5-bromo-3-benzo thienyl methylamine hydrochloride)
were used. Solutions of each drug were freshly made up immediately before use
according to the manufacturer's instructions. The drugs were administered by
intraperitoneal injection in 1-0 ml. volumes. Control animals received 10 ml.
Of N saline by the same route.
Pinkel (1958) has shown that the effects of cytotoxic agents in animals of
different species are more nearly comparable if dosages are related to surface area
rather than to body-weight. From this observation, Freireich et al., (1966) have
calculated that a human dose level, measured on a body-weight basis, can be
converted to an approximately equivalent body-weight dosage in the rat by
multiplication by a conversion factor of 7.J. A. GORDON, G. M. R. SMITH AND H. ELLIS
In the present study doses of 0-4 mg./kg. of nitrogen mustard, 0-025 mg./kg.
of streptonigrin, and 2-0 mg./kg. of A.G.N. 1414 were chosen as total human
dosages. These were then converted to total murine dose levels of 2-8 mg./kg.,
0-175 mg./kg., and 14-0 mg./kg., respectively, which were used in the experiments.
The effects ofnitrogen mustard in lower doses were also examined.
TREATMENTS USED
Nitrogen mustard
1. Single total doses immediately after operation. 0-135 mg., 0-2 mg., and
0.9 mg.
2. Single total doses 3 days after operation. 0S8 mg. and 0-9 mg.
3. Divided doses from 1 day pre-operatively. 0.1 mg./day x 8, 0K15
mg./day x 5.
Streptonigrin
1. Divided doses from 1 day pre-operatively. 0-0125 mg./day x 4.
2. Divided doses from immediately after operation. 0-0125 mg./day x 4.
3. Divided doses from 4 days postoperatively. 0-0125 mg./day x 4.
A.G.N. 1414
1. Divided doses from 1 day pre-operatively. 1-0 mg./day x 4.
2. Single total dose immediately after operation. 4-0 mg.
3. Single total dose 3 days postoperatively. 4-0 mg.
Oontrol8.
1.0 ml. N saline.
Cytotoxic drugs were administered to 55 rats in all. Each dose was given to at
least 2 animals. Two or more control rats were used for comparison at each dose
level. The animals were killed atintervals varying from 1-21 days afteroperation.
The peritoneal defects were excised immediately and fixed in 10% formalin.
Blood was taken for W.B.C. counts at the time of killing from representatives of
each group. Seventeen rats died from drug toxicity or other causes. These
animals were excluded from the study.
Histological Examination
Haematoxylin and eosin, haematoxylin and van Gieson, and phosphotungstic
acid and haematoxylin stained sections of the peritoneal defects were examined
EXPLANATION OF PLATES
FIG. 1.-Peritoneal defect in untreated control rat at 5 days. H. and E. x 40.
FIG. 2. Peritoneal defect in rat treated with nitrogen mustard 0-15 mg./day x 5 at 5 days.
H. and E. x 40.
FIG. 3.-Peritoneal defect in untreated control rat at 7 days. H. and E. x 35.
FIG. 4.-Peritoneal defect in rat treated with streptonigrin 0-0125 mg./day x 4 at 7 days.
H.andE. x35.
FIG. 5.-Peritoneal defect in rat treated with A.G.N. 1414, 4 mg./day x 1 at 7 days. H. and
E. x35.
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microscopically. The healing ofthe defects was compared in animals treated with
cytotoxic drugs and in untreated controls.
RESULTS
The process of normal healing in the rat has already been fully described from
this department (Ellis, Harrison and Hugh, 1965).
No difference was observed in peritoneal healing in rats treated with cytotoxic
drugs and in untreated controls. There was no histological evidence of any
diminution of fibroblastic activity in the animals receiving cytotoxic drugs, even
at the highest dose levels, and in each case wound healing appeared to be pro-
gressing normally (Fig. 1-5). In no instance did the W.B.C. counts fall below
normal limits.
DISCUSSION
Following the demonstration by Cole and his colleagues (McDonald et al.,
1957; Morales et al., 1957) that nitrogen mustard may prevent the establishment
and growth of free tumour cells in rats, if given at the time of implantation or
soon afterwards, it has become an accepted surgical practice to administer cyto-
toxic drugs, either locally or systemically, at the time of operation for malignant
disease as a prophylaxis against the seeding of tumour cells. Intraperitoneal
administration of these agents has also commonly been used in the treatment of
inoperable intra-abdominal cancer with metastatic peritoneal spread. It is
known, however, that cytotoxic drugs have a destructive action on all rapidly
dividing tissues, both normal and neoplastic, and therefore interference with the
processes of wound healing may be expected from their use.
For this reason the effects of these agents on the healing of surgical wounds
should always be known before they are used in combination with surgery. The
fact that many patients who undergo major operations for malignant disease are
already debilitated, and more than usually liable to postoperative complications,
makes this additionally necessary. Therefore, as each new cytotoxic drug is
developed for clinical use, its effects on wound healing should also be carefully
examined.
Although several studies have been made of the effect of cytotoxic agents on
the healing of skin wounds and full-thickness abdominal incisions, the influence
of these drugs on the healing of peritoneum has not been investigated before.
However, this is a subject of considerable interest for peritoneal healing plays an
important part in the repair ofall laparotomy incisions, and also ofthe considerable
peritoneal defects which may be left after some operations, such as excision of the
colon, for intra-abdominal cancer.
The effects of nitrogen mustard on wound healing have been investigated
before, but the effects of streptonigrin and A.G.N. 1414 have not been examined
previously. Studies ofthe healing ofsurgical incisions in rats (Farhat et al., 1958),
mice (Harris and Thomas, 1961), and rabbits (Hatiboglu et al., 1960) have demon-
strated that local or systemic treatment with nitrogen mustard may reduce the
tensile strength of healing wounds. Conn, Leb and Hardy (1957), however,
were unable to detect any effect of systemic nitrogen mustard on the healing of
gastrotomy incisions in dogs. In these studies histological examination of the
healing wounds revealed no diminution of fibroblastic activity in animals receiving
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cytotoxic drugs, but Hardesty (1958) has reported that in rats nitrogen mustard
may have an inhibitory effect on fibroblastic proliferation when administered
either locally at the wound or intravenously at the time of wounding.
These conflicting results are possibly due in part to difficulties in measuring
accurately the tensile strength of wounds, and also in assessing fibroblastic
activity in healing surgical incisions. In this respect the healing of simple
peritoneal defects is much easier to evaluate histologically. Differences in the
species ofexperimental animals used, and in the dosages and routes ofadministra-
tion of the drugs, too, may account for some of the inconsistencies in the findings
previously reported.
It is known also that the timing oftherapy in relation to the operative procedure
has a special relevance in studies of this type. Newcombe (1966), for example,
has shown that although 0*5 mg./kg. of nitrogen mustard, if administered intra-
arterially at the time of wounding, has no effect on the healing of skin wounds
in rabbits, the same dose given 3 days later has a marked effect on wound healing.
Calnan and Davies (1965), too, have shown that the administration of metho-
trexate has a greater inhibitory action on healing if given after wounding than if
given before, or both before and after, the wound is made.
In the present histological study several dosage regimes have been used. And
the cytotoxic agents have been administered before, at the time of, and after the
operative procedure. An attempt has also been made to use dosages in the rat
which are approximately equivalent in effect to the dose levels normally used
clinically. The results of these experiments, which demonstrate that nitrogen
mustard, streptonigrin, and A.G.N. 1414 have no effect on the healing of small
peritoneal defects in rats, may therefore perhaps be taken to indicate that these
agents can be safely administered intraperitoneally immediately before, during,
or after surgery in the clinical treatment of intra-abdominal malignant disease
without significantly impairing peritoneal healing.
SUMMARY
A histological study of the effects of the cytotoxic drugs nitrogen mustard,
streptonigrin and A.G.N. 1414 administered intraperitoneally in various dosage
regimes has shown that these agents do not impair the healing of peritoneal
wounds in the rat.
Streptonigrin was suppliedby theJohn L. Smith Memorial for Cancer Research,
Chas. Pfizer and Co. Inc., Maywood, New Jersey, U.S.A., where the compound was
produced under contract P.H. 43-64-50 with Collaborative Research, U.S.
National Cancer Institute, U.S. Public Health Service.
A.G.N. 1414 was supplied by The Nicholas Research Institute Ltd., Slough,
Bucks., England.
This study was supported by funds from the British Empire Cancer Campaign
for Research and one of us (G.M.R.S.) was employed as a Research Assistant by
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